Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Liuwei Dihuang Wan (Henan Bainian Kangxin Pharmaceutical)
- Development stage
- Unknown
- Lead developer
- Henan Bainian Kangxin Pharmaceutical
- Administration
- Oral
01
Overview
Liuwei Dihuang Wan (Six-Ingredient Rehmannia Pill) is a classical Traditional Chinese Medicine (TCM) formula marketed by Henan Bainian Kangxin Pharmaceutical. The formulation is composed of six herbal ingredients: *Radix Rehmanniae praeparata* (Shu Di Huang), *Fructus Corni* (Shan Zhu Yu), *Rhizoma Dioscoreae* (Shan Yao), *Rhizoma Alismatis* (Ze Xie), *Cortex Moutan* (Mu Dan Pi), and *Poria Cocos* (Fu Ling), typically prepared in an 8:4:4:3:3:3 ratio. In TCM theory, it is used to nourish kidney-yin and supplement kidney essence. It is indicated for symptoms associated with kidney-yin deficiency, including dizziness, tinnitus, soreness and weakness of the waist and knees, night sweats, and 'steaming bone' sensations. As a multi-component herbal product, it functions through the synergistic effects of various phytochemicals rather than a single molecular target.
- Brand names
- Liuwei Dihuang Wan
- Other names
- Six-Ingredient Rehmannia PillLiuwei Dihuang PillsSix-Ingredient Rehmannia Formula
Beyond the preview
Go deeper on Liuwei Dihuang Wan (Henan Bainian Kangxin Pharmaceutical).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Liuwei Dihuang Wan (Henan Bainian Kangxin Pharmaceutical).